Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 01:55PM ET
11.51
Dollar change
-0.53
Percentage change
-4.40
%
IndexRUT P/E- EPS (ttm)-3.14 Insider Own13.47% Shs Outstand42.19M Perf Week-7.62%
Market Cap485.71M Forward P/E- EPS next Y-2.66 Insider Trans-0.13% Shs Float36.52M Perf Month-10.01%
Income-115.38M PEG- EPS next Q-0.72 Inst Own89.97% Short Float15.81% Perf Quarter-11.80%
Sales89.36M P/S5.44 EPS this Y13.12% Inst Trans-8.84% Short Ratio10.14 Perf Half Y-9.51%
Book/sh0.60 P/B19.03 EPS next Y13.62% ROA-46.56% Short Interest5.77M Perf Year-19.23%
Cash/sh5.94 P/C1.94 EPS next 5Y- ROE- 52W Range10.60 - 20.70 Perf YTD-23.27%
Dividend Est.- P/FCF- EPS past 5Y5.89% ROI-78.26% 52W High-44.40% Beta1.07
Dividend TTM- Quick Ratio8.77 Sales past 5Y13144.25% Gross Margin90.27% 52W Low8.58% ATR (14)0.61
Dividend Ex-Date- Current Ratio9.00 EPS Y/Y TTM25.65% Oper. Margin-93.70% RSI (14)39.64 Volatility4.11% 5.00%
Employees201 Debt/Eq4.81 Sales Y/Y TTM15.64% Profit Margin-129.11% Recom1.29 Target Price39.93
Option/ShortYes / Yes LT Debt/Eq4.78 EPS Q/Q18.93% Payout- Rel Volume0.55 Prev Close12.04
Sales Surprise4.13% EPS Surprise32.69% Sales Q/Q20.87% EarningsNov 06 BMO Avg Volume569.59K Price11.51
SMA20-4.30% SMA50-5.93% SMA200-18.74% Trades Volume216,479 Change-4.40%
Date Action Analyst Rating Change Price Target Change
Aug-22-24Initiated Guggenheim Buy $40
Feb-08-23Downgrade Jefferies Buy → Hold $35 → $10
Apr-27-22Initiated Berenberg Buy $20
Apr-16-20Reiterated H.C. Wainwright Buy $53 → $57
Apr-13-20Reiterated H.C. Wainwright Buy $75 → $53
Jan-09-20Initiated National Securities Neutral $37
May-30-19Initiated JP Morgan Neutral
May-29-19Initiated Goldman Neutral
Jan-29-19Initiated H.C. Wainwright Buy $82
Nov-08-18Resumed Jefferies Buy
Dec-06-24 08:00AM
Dec-05-24 03:30PM
03:15PM
Dec-02-24 05:44PM
08:00AM
11:49AM Loading…
Nov-28-24 11:49AM
Nov-26-24 08:00AM
Nov-07-24 02:16AM
Nov-06-24 09:15AM
08:00AM
Nov-05-24 08:00AM
Oct-30-24 08:00AM
Oct-28-24 08:00AM
Oct-16-24 04:47AM
Oct-15-24 04:30PM
06:18PM Loading…
Oct-09-24 06:18PM
08:00AM
Oct-03-24 04:12AM
Oct-02-24 08:00AM
Sep-23-24 05:50AM
03:58AM
Sep-16-24 08:00AM
Sep-05-24 08:00AM
Aug-29-24 08:00AM
Aug-14-24 08:00AM
Aug-13-24 09:15AM
08:00AM
Aug-05-24 08:00AM
Aug-02-24 09:55AM
Aug-01-24 10:01AM
09:55AM Loading…
Jul-17-24 09:55AM
Jun-27-24 01:54PM
Jun-17-24 10:51PM
04:46PM
05:00AM
Jun-13-24 04:05PM
10:45AM
Jun-07-24 08:00AM
Jun-06-24 08:00AM
Jun-05-24 08:00AM
Jun-03-24 08:00AM
May-22-24 08:00AM
May-14-24 08:20AM
May-13-24 12:53PM
09:32AM
08:00AM
May-07-24 08:00AM
May-05-24 12:20PM
May-04-24 03:20PM
11:50AM
May-03-24 08:00AM
Apr-17-24 12:02PM
Apr-15-24 08:00AM
Apr-03-24 08:00AM
Mar-15-24 10:30AM
Mar-14-24 12:53PM
09:32AM
09:10AM
08:00AM
Mar-08-24 08:00AM
Mar-04-24 08:00AM
Feb-26-24 08:00AM
Feb-01-24 08:00AM
Jan-24-24 08:00AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Dec-08-23 04:00PM
Nov-15-23 01:50PM
Nov-14-23 12:19PM
08:00AM
Nov-13-23 08:00AM
Nov-07-23 08:00AM
Oct-03-23 08:00AM
Sep-11-23 07:00AM
Sep-08-23 08:00AM
Aug-31-23 08:00AM
Aug-18-23 01:40PM
Aug-17-23 07:00AM
Aug-12-23 09:18AM
Aug-10-23 09:55AM
09:15AM
08:00AM
Aug-08-23 08:00AM
Aug-02-23 05:00PM
Aug-01-23 10:05AM
Jul-31-23 08:00AM
Jul-28-23 01:41PM
Jul-27-23 09:55AM
09:50AM
Jul-25-23 04:10PM
Jul-10-23 08:00AM
Jul-06-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 08:00AM
Jun-02-23 08:00AM
May-22-23 01:18PM
May-16-23 12:13PM
May-11-23 09:15AM
08:00AM
May-04-23 08:00AM
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoenberg MarkChief Medical OfficerSep 09 '24Sale13.0885911,236145,091Sep 12 01:54 PM
Smith Jason DrewGeneral CounselSep 09 '24Sale13.081,52119,89525,226Sep 12 01:51 PM
Schoenberg MarkOfficerSep 09 '24Proposed Sale13.2385911,365Sep 10 07:16 AM
Schoenberg MarkChief Medical OfficerJun 10 '24Sale13.085,15367,401144,284Jun 11 01:15 PM
Schoenberg MarkChief Medical OfficerMar 18 '24Sale14.0512,000168,600139,437Mar 20 04:38 PM
Smith Jason DrewGeneral CounselJan 31 '24Sale15.744,99378,59018,824Feb 02 07:12 PM
Schoenberg MarkChief Medical OfficerJan 31 '24Sale15.743,78959,639149,423Feb 02 07:07 PM